Conduit Pharmaceuticals Inc
NASDAQ:CDT
Fundamental Analysis

Revenue & Expenses Breakdown
Conduit Pharmaceuticals Inc
Balance Sheet Decomposition
Conduit Pharmaceuticals Inc
Current Assets | 5.9m |
Cash & Short-Term Investments | 2.1m |
Other Current Assets | 3.8m |
Non-Current Assets | 1.4m |
PP&E | 275k |
Other Non-Current Assets | 1.1m |
Free Cash Flow Analysis
Conduit Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Conduit Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-16.5m
USD
|
Operating Income
|
-16.5m
USD
|
Other Expenses
|
-2.9m
USD
|
Net Income
|
-19.4m
USD
|
CDT Profitability Score
Profitability Due Diligence
Conduit Pharmaceuticals Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Conduit Pharmaceuticals Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
CDT Solvency Score
Solvency Due Diligence
Conduit Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Conduit Pharmaceuticals Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CDT Price Targets Summary
Conduit Pharmaceuticals Inc
Dividends
Current shareholder yield for CDT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?